Riskpilot← Back to searchSign inGet full accessWong & Blain Diagnostics AB
ABActiveOrg 5592204563Gibraltargatan 110 Lgh Nr 0902General medical practice activities · NACE 8621Est. 20190 employees
Revenue 2025
SEK 9K
-93% vs 2024
EBITDA margin
-612.9%
+5% vs 2024
Equity ratio
96.1%
Financial strength
Net profit 2025
SEK -75K
+17% vs 2024
| Revenue | SEK 9K | -93% |
| EBITDA | SEK -57K | +5% |
| Net profit | SEK -75K | +17% |
| Total assets | SEK 164K | -31% |
| Equity | SEK 157K | -32% |
| Employees | 0 | — |
Legal name
Wong & Blain Diagnostics AB
Org number
5592204563
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
30 september 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet ska bedriva konsulterande tjänster inom sjukvårdsområdet i form av medicinsk konsultation, medicinsk bilddiagnostik, utbildning, handel med värdepapper, äga och förvalta fastigheter i Sverige och utomlands.
Address
Gibraltargatan 110 Lgh Nr 0902
Email
wawong191987@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 43 | 1 467 | 659 | 129 | 9 |
| Staff expenses | — | −83 | −346 | −66 | −0 |
| EBITDA | 31 | 1 181 | −41 | −61 | −57 |
| Depreciation & amort. | −6 | −14 | −21 | −21 | −18 |
| EBIT | 25 | 1 167 | −63 | −82 | −75 |
| Net financials | — | — | 0 | −8 | 0 |
| Profit before tax | 23 | 1 169 | −63 | −90 | −75 |
| Tax | −0 | −191 | — | — | — |
| Net profit | 23 | 978 | −63 | −90 | −75 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 80 | 1 234 | 600 | 239 | 164 |
| Equity | 59 | 1 037 | 323 | 233 | 157 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 19 | 197 | 277 | 6 | 6 |
| Total debt | 19 | 197 | 277 | 6 | 6 |
EBITDA margin
-612.9%
This company
15.8%
Market median
-3979% vs market
20212025
Equity ratio
96.1%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
-47.8%
This company
18.4%
Market median
-360% vs market
20212025
Net profit margin
-802.3%
This company
8.1%
Market median
-10005% vs market
20212025
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
EB Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2026 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wong & Blain Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elena Blain | Chief Executive Officer | 0 companies |
| Bianca Isabelle Blain | Deputy Board Member | 0 companies |
| Wing-Kee Andrew Wong | Board of Directors | 0 companies |
| Wing-Tsi Henry Wong | Deputy Board Member | 0 companies |